Gary G. Altman
Directeur des opérations chez Calcite Credit Union
Profil
Gary G.
Altman is the founder of Sequoia Pharmaceuticals, Inc. He currently holds the position of Director at Provista Diagnostics, Inc., Managing Director at Altman & Associates, Director at Teamedon International, Inc., and Chief Operating Officer at Calcite Credit Union.
Previously, he served as President, Chief Executive Officer & Director at Icagen, Inc. from 2013 to 2014, Chief Executive Officer at Sandstone Diagnostics, Inc., Chief Scientific Officer at The Hillshire Brands Co., and VP-Global Strategy, Market & Business Development at Beckman Coulter, Inc. from 2008 to 2011.
Postes actifs de Gary G. Altman
| Sociétés | Poste | Début |
|---|---|---|
Altman & Associates
 Altman & Associates Miscellaneous Commercial ServicesCommercial Services Altman & Associates is a private company based in Rockville, MD. | Corporate Officer/Principal | 01/04/2001 |
Provista Diagnostics, Inc.
 Provista Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provista Diagnostics, Inc. operates as a diagnostic company. It focuses on the development and commercialization of proprietary blood based diagnostic, prognostic, and monitoring tests in women's cancer. Its products include videssa breast, ovarian, endometrial, and HPV associated. The company is headquartered in Alpharetta, GA. | Directeur/Membre du Conseil | - |
Calcite Credit Union
 Calcite Credit Union Savings BanksFinance Part of Alpena-Alcona Area Credit Union, Calcite Credit Union is a financial institution that offers a range of services such as savings and checking accounts, loans, investments, and e-services. The company is based in Rogers City, MI. Mills. The company was founded in 1961, and the CEO is Barbara J. Calcite Credit Union was acquired by Alpena-Alcona Area Credit Union on March 18, 2023. | Directeur des opérations | - |
Teamedon International, Inc.
 Teamedon International, Inc. Pharmaceuticals: MajorHealth Technology Teamedon International, Inc. develops novel therapeutics to combat leukemia. The company was founded on May 22, 2017 and is headquartered in Lewes, DE. | Directeur/Membre du Conseil | - |
Anciens postes connus de Gary G. Altman
| Sociétés | Poste | Fin |
|---|---|---|
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | Directeur Général | 23/09/2014 |
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Corporate Officer/Principal | 01/01/2011 |
Sandstone Diagnostics, Inc.
 Sandstone Diagnostics, Inc. Medical/Nursing ServicesHealth Services Sandstone Diagnostics, Inc. provides instruments and consumables for point-of-care medical testing. Its products include Torq ZDisc and Torq microvolume rotor. The company was founded by Gregory Sommer, Sara Naab Schaff and Ulrich Schaff in 2012 and is headquartered in Livermore, CA. | Directeur Général | - |
Sequoia Pharmaceuticals, Inc.
 Sequoia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sequoia Pharmaceuticals discovers and develops unique treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis with a focus on the growing global problem of drug-resistant disease. Most new anti-viral drugs were designed to block the most prevalent form of a pathogen, but these drugs become less potent due to the emergence of drug-resistant mutations. Sequoia's is to discover and develop new antiviral which are active against the most prevalent form of the virus but also anticipates the emergence of drug resistance forms thereby maintaining potency over time. Sequoia's differentiating approach is to identify a constellation of atomic interaction points which are necessary and sufficient for enzymatic function. Sequoia's protease inhibitors have been designed to interact preferentially with only these atoms, thus allowing non-critical mutations to occur without resulting in a decrease in drug potency. The foundation of Sequoia's novel Resistant-Repellent™ technology is a drug discovery tool that enhances the efficiency with which drugs are designed. It is based on an understanding of the chemical and physical nature of the molecular targets, the enzymes and receptors to which drugs bind, combined with an understanding of the molecular mechanisms that cause drug resistance. Sequoia is also discovering and developing a unique series of pharmacokinetic enhancers (PKEs) to work in combination with its own, and its partners', antiviral therapies. These sets of molecules improve the PK of existing therapeutics and reduce interpatient variability. This represents a unique approach to an important need in HIV treatment today. Sequoia is also looking to extend this novel PKE approach to other areas. Its PKEs are designed to inhibit a particular CYP isozyme and therefore change the metabolism of a co-administered therapeutic agent. The combination of PK Enhancer and the therapeutic agent enables reduced dosage and less frequent administration of the therapeutic agent. | Fondateur | - |
| HILLSHIRE BRANDS CO | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
The Hillshire Brands Co.
 The Hillshire Brands Co. Food: Meat/Fish/DairyConsumer Non-Durables The Hillshire Brands Co. provides meat-centric food solutions for the retail and foodservice markets. The company was founded by Nathan Cummings in 1939 and is headquartered in Chicago, IL. | Consumer Non-Durables |
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Health Technology |
Sequoia Pharmaceuticals, Inc.
Sequoia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sequoia Pharmaceuticals discovers and develops unique treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis with a focus on the growing global problem of drug-resistant disease. Most new anti-viral drugs were designed to block the most prevalent form of a pathogen, but these drugs become less potent due to the emergence of drug-resistant mutations. Sequoia's is to discover and develop new antiviral which are active against the most prevalent form of the virus but also anticipates the emergence of drug resistance forms thereby maintaining potency over time. Sequoia's differentiating approach is to identify a constellation of atomic interaction points which are necessary and sufficient for enzymatic function. Sequoia's protease inhibitors have been designed to interact preferentially with only these atoms, thus allowing non-critical mutations to occur without resulting in a decrease in drug potency. The foundation of Sequoia's novel Resistant-Repellent™ technology is a drug discovery tool that enhances the efficiency with which drugs are designed. It is based on an understanding of the chemical and physical nature of the molecular targets, the enzymes and receptors to which drugs bind, combined with an understanding of the molecular mechanisms that cause drug resistance. Sequoia is also discovering and developing a unique series of pharmacokinetic enhancers (PKEs) to work in combination with its own, and its partners', antiviral therapies. These sets of molecules improve the PK of existing therapeutics and reduce interpatient variability. This represents a unique approach to an important need in HIV treatment today. Sequoia is also looking to extend this novel PKE approach to other areas. Its PKEs are designed to inhibit a particular CYP isozyme and therefore change the metabolism of a co-administered therapeutic agent. The combination of PK Enhancer and the therapeutic agent enables reduced dosage and less frequent administration of the therapeutic agent. | Health Technology |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | Health Technology |
Sandstone Diagnostics, Inc.
Sandstone Diagnostics, Inc. Medical/Nursing ServicesHealth Services Sandstone Diagnostics, Inc. provides instruments and consumables for point-of-care medical testing. Its products include Torq ZDisc and Torq microvolume rotor. The company was founded by Gregory Sommer, Sara Naab Schaff and Ulrich Schaff in 2012 and is headquartered in Livermore, CA. | Health Services |
Provista Diagnostics, Inc.
Provista Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provista Diagnostics, Inc. operates as a diagnostic company. It focuses on the development and commercialization of proprietary blood based diagnostic, prognostic, and monitoring tests in women's cancer. Its products include videssa breast, ovarian, endometrial, and HPV associated. The company is headquartered in Alpharetta, GA. | Commercial Services |
Altman & Associates
Altman & Associates Miscellaneous Commercial ServicesCommercial Services Altman & Associates is a private company based in Rockville, MD. | Commercial Services |
Calcite Credit Union
Calcite Credit Union Savings BanksFinance Part of Alpena-Alcona Area Credit Union, Calcite Credit Union is a financial institution that offers a range of services such as savings and checking accounts, loans, investments, and e-services. The company is based in Rogers City, MI. Mills. The company was founded in 1961, and the CEO is Barbara J. Calcite Credit Union was acquired by Alpena-Alcona Area Credit Union on March 18, 2023. | Finance |
Teamedon International, Inc.
Teamedon International, Inc. Pharmaceuticals: MajorHealth Technology Teamedon International, Inc. develops novel therapeutics to combat leukemia. The company was founded on May 22, 2017 and is headquartered in Lewes, DE. | Health Technology |
